MGO One Seven’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

MGO One Seven’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$598K	–	905
2022 Q4	$598K	Hold	40,000	–	–	0.06%	341
2022 Q3	$329	Hold	40,000	–	–	0.01%	509
2022 Q2	$262K	Hold	40,000	–	–	0.04%	501
2022 Q1	$224K	Buy	40,000 +30,000	+300%	+$124K	0.02%	588
2021 Q4	$47K	Hold	10,000	–	–	﹤0.01%	658
2021 Q3	$68K	Hold	10,000	–	–	0.01%	598
2021 Q2	$66K	Hold	10,000	–	–	0.01%	585
2021 Q1	$73K	Hold	10,000	–	–	0.01%	544
2020 Q4	$58K	Hold	10,000	–	–	0.01%	489
2020 Q3	$59K	Buy	+10,000	New	+$49.5K	0.01%	462
2019 Q2	–	Sell	-2,700	Closed	-$22K	–	443
2019 Q1	$22K	Hold	2,700	–	–	0.01%	417
2018 Q4	$43K	Hold	2,700	–	–	0.02%	670
2018 Q3	$89K	Buy	+2,700	New	+$69.4K	0.04%	347
2018 Q1	$78K	Hold	2,700	–	–	0.04%	499
2017 Q4	$75K	Buy	+2,700	New	+$83.8K	0.03%	505

MGO One Seven's AVEO Position: Q1 2023 in Review

MGO One Seven sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 40,000 shares — an estimated $598K sold.

MGO One Seven first reported a position in AVEO in Q4 2017 and held it in 15 quarters. The position peaked at $598K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

MGO One Seven reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
MGO One Seven sold 40,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $598K.
MGO One Seven first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 15 quarters.
MGO One Seven's AVEO Pharmaceuticals, Inc. position peaked at $598K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on MGO One Seven's 13F filing for Q1 2023, filed 8 May 2023.